Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multi-centre randomised controlled trial (the GREAT trial).
dc.contributor.author | Clare, L | |
dc.contributor.author | Kudlicka, A | |
dc.contributor.author | Oyebode, JR | |
dc.contributor.author | Jones, RW | |
dc.contributor.author | Bayer, A | |
dc.contributor.author | Leroi, I | |
dc.contributor.author | Kopelman, M | |
dc.contributor.author | James, IA | |
dc.contributor.author | Culverwell, A | |
dc.contributor.author | Pool, J | |
dc.contributor.author | Brand, A | |
dc.contributor.author | Henderson, C | |
dc.contributor.author | Hoare, Z | |
dc.contributor.author | Knapp, M | |
dc.contributor.author | Woods, B | |
dc.date.accessioned | 2019-03-07T12:51:33Z | |
dc.date.issued | 2019-03-01 | |
dc.description.abstract | OBJECTIVES: To determine whether individual goal-oriented cognitive rehabilitation (CR) improves everyday functioning for people with mild-to-moderate dementia. DESIGN AND METHODS: Parallel group multi-centre single-blind randomised controlled trial (RCT) comparing CR added to usual treatment (CR) with usual treatment alone (TAU) for people with an ICD-10 diagnosis of Alzheimer's, vascular or mixed dementia and mild-to-moderate cognitive impairment (MMSE score ≥ 18), and with a family member willing to contribute. Participants allocated to CR received ten weekly sessions over three months and four maintenance sessions over six months. Participants were followed up three and nine months post-randomisation by blinded researchers. The primary outcome was self-reported goal attainment at three months. Secondary outcomes at three and nine months included informant-reported goal attainment, quality of life, mood, self-efficacy, and cognition, and study partner stress and quality of life. RESULTS: We randomised (1:1) 475 people with dementia; 445 (CR=281) were included in the intention to treat analysis at three months, and 426 (CR=208) at nine months. At three months there were statistically-significant large positive effects for participant-rated goal attainment (d=0.97, 95% CI 0.75 to 1.19), corroborated by informant ratings (d=1.11, 0.89 to 1.34). These effects were maintained at nine months for both participant (d=0.94, 0.71 to 1.17) and informant ratings (d=0.96, 0.73 to 1.2). The observed gains related to goals directly targeted in the therapy. There were no significant differences in secondary outcomes. CONCLUSIONS: Cognitive rehabilitation enables people with early-stage dementia to improve their everyday functioning in relation to individual goals targeted in the therapy. | en_GB |
dc.description.sponsorship | National Institute for Health | en_GB |
dc.identifier.citation | Published online 06 February 2019 | en_GB |
dc.identifier.doi | 10.1002/gps.5076 | |
dc.identifier.grantnumber | 11/15/04 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/36342 | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/30724405 | en_GB |
dc.rights | © 2019 The Authors. International Journal of Geriatric Psychiatry Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | en_GB |
dc.subject | Alzheimer's disease | en_GB |
dc.subject | activities of daily living | en_GB |
dc.subject | disability | en_GB |
dc.subject | goal-setting | en_GB |
dc.subject | non-pharmacological intervention | en_GB |
dc.subject | person-centred | en_GB |
dc.subject | problem-solving | en_GB |
dc.subject | reablement | en_GB |
dc.subject | vascular dementia | en_GB |
dc.title | Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multi-centre randomised controlled trial (the GREAT trial). | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-03-07T12:51:33Z | |
dc.identifier.issn | 0885-6230 | |
exeter.place-of-publication | England | en_GB |
dc.description | This is the final version. Available from the publisher via the DOI in this record. | en_GB |
dc.description | Requests to access the full quantitative dataset may be directed to thelead author (L.C.) | en_GB |
dc.identifier.journal | International Journal of Geriatric Psychiatry | en_GB |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | en_GB |
dcterms.dateAccepted | 2019-01-28 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2019-03-01 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-03-07T12:43:02Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2019-03-07T12:51:35Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2019 The Authors. International Journal of Geriatric Psychiatry Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.